Isolation and evaluation of immunological adjuvant activities of saponins from the roots of Pulsatilla chinensis with less adverse reactions

被引:61
作者
Sun, Yongxu [1 ]
Liu, Jicheng [1 ]
Yu, Haitao [1 ]
Gong, Chunjie [2 ]
机构
[1] Qiqihar Med Univ, Dept Med Chem & Biomacromol, Qiqihar 161042, Peoples R China
[2] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan
关键词
Pulsatilla chinensis; Saponins; Haemolytic; Adjuvants; Proliferation; Antibody; T-CELL RESPONSES; HEMOLYTIC ACTIVITIES; IMMUNE-RESPONSES; TRITERPENE GLYCOSIDES; CYTOKINE PRODUCTION; VACCINE ADJUVANTS; TH1; CLONES; QS-21; MICE; ANTIBODY;
D O I
10.1016/j.intimp.2010.02.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study, the saponins (PCS) from the roots of Pulsatilla chinensis were evaluated for its haemolytic activity, acute toxicity and tested for potential adjuvant activity in mice immunized with ovalbumin (OVA) compared with that of Quil A saponin. The haemolytic activity of PCS was determined using 0.5% rabbit red blood cell with values of 15.41 and 7.42% at concentrations of 500 and 250 mu g/mL, respectively. The saponins were tested for their toxicity by lethality in mice and were found to be less toxic at the same dose than their counterpart Quil A. ICR mice were immunized subcutaneously with OVA 100 mu g in phosphate-buffered saline (PBS) alone or with OVA 100 mu g in the presence of Quil A (10 mu g) or PCS (50, 100 or 200 mu g) twice at a 2-week interval. Four weeks later, the ConA-, LPS-, and OVA-induced splenocyte proliferation, OVA-specific antibodies levels (IgG, IgG1, and IgG2a) in serum, IL-2, and TNF-alpha were significantly enhanced by PCS at a high dose compared to that induced by Quil A. The P values of various testing activities in saponin-treated groups were obviously differential to that in the OVA-immunized mice (p<0.05 or p<0.01). This finding suggested that PCS might have an effect on Th1 and Th2 helper T cells. In conclusion, the results indicated that PCS showed slight side effects and at an appropriate dose could be used as a vaccine adjuvant to increase immune responses. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:584 / 590
页数:7
相关论文
共 58 条
  • [21] Glenny A., 1926, J PATHOL BACTERIOL, V29, P38
  • [22] GOTO N, 1993, VACCINE, V11, P914, DOI 10.1016/0264-410X(93)90377-A
  • [23] Aluminum compounds as vaccine adjuvants
    Gupta, RK
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1998, 32 (03) : 155 - 172
  • [24] Gupta RK., 1995, Vaccine design: the subunit and adjuvant approach, P229
  • [25] HE X, 1987, ZHONG CAO YAO, V18, P15
  • [26] HOSTETTMANN K, 1996, SAPONINS USED TRADIT, P87
  • [27] Kensil C R, 1995, Pharm Biotechnol, V6, P525
  • [28] KENSIL CR, 1991, J IMMUNOL, V146, P431
  • [29] Konoshima T, 1996, ADV EXP MED BIOL, V404, P87
  • [30] QS-21 structure/function studies: effect of acylation on adjuvant activity
    Liu, G
    Anderson, C
    Scaltreto, H
    Barbon, J
    Kensil, CR
    [J]. VACCINE, 2002, 20 (21-22) : 2808 - 2815